{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:31:26Z","timestamp":1786433486233,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021726","name":"Direktorat Riset and Pengembangan, Universitas Indonesia","doi-asserted-by":"publisher","award":["PUTI Q2 Research Grant (Number: NKB-651\/UN2.RST\/HKP.05.00\/2024)"],"award-info":[{"award-number":["PUTI Q2 Research Grant (Number: NKB-651\/UN2.RST\/HKP.05.00\/2024)"]}],"id":[{"id":"10.13039\/501100021726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021726","name":"Direktorat Riset and Pengembangan, Universitas Indonesia","doi-asserted-by":"publisher","award":["PUTI Q2 Research Grant (Number: NKB-651\/UN2.RST\/HKP.05.00\/2024)"],"award-info":[{"award-number":["PUTI Q2 Research Grant (Number: NKB-651\/UN2.RST\/HKP.05.00\/2024)"]}],"id":[{"id":"10.13039\/501100021726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021726","name":"Direktorat Riset and Pengembangan, Universitas Indonesia","doi-asserted-by":"publisher","award":["PUTI Q2 Research Grant (Number: NKB-651\/UN2.RST\/HKP.05.00\/2024)"],"award-info":[{"award-number":["PUTI Q2 Research Grant (Number: NKB-651\/UN2.RST\/HKP.05.00\/2024)"]}],"id":[{"id":"10.13039\/501100021726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021726","name":"Direktorat Riset and Pengembangan, Universitas Indonesia","doi-asserted-by":"publisher","award":["PUTI Q2 Research Grant (Number: NKB-651\/UN2.RST\/HKP.05.00\/2024)"],"award-info":[{"award-number":["PUTI Q2 Research Grant (Number: NKB-651\/UN2.RST\/HKP.05.00\/2024)"]}],"id":[{"id":"10.13039\/501100021726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12576-2","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:10:30Z","timestamp":1786432230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stem-like characteristics across sequentially temozolomide-adapted glioblastoma cell populations with increasing levels of acquired resistance"],"prefix":"10.1007","volume":"53","author":[{"given":"Dewi Hambar","family":"Sari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Septelia Inawati","family":"Wanandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renindra Ananda","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivi","family":"Kasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"12576_CR1","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/cancers14102412","volume":"14","author":"S Grochans","year":"2022","unstructured":"Grochans S, Cybulska AM, Simi\u0144ska D et al (2022) Epidemiology of Glioblastoma Multiforme\u2013Literature Review. Cancers 14:2412. https:\/\/doi.org\/10.3390\/cancers14102412","journal-title":"Cancers"},{"key":"12576_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3322\/caac.21693","volume":"71","author":"KD Miller","year":"2021","unstructured":"Miller KD, Ostrom QT, Kruchko C et al (2021) Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin 71:381\u2013406. https:\/\/doi.org\/10.3322\/caac.21693","journal-title":"CA Cancer J Clin"},{"key":"12576_CR3","doi-asserted-by":"publisher","first-page":"100685","DOI":"10.1016\/j.device.2024.100685","volume":"3","author":"K Mnich","year":"2025","unstructured":"Mnich K, Lhomond S, Wallace E et al (2025) Improving glioblastoma treatment with imaging, radiotherapy, drug delivery, and therapeutic systems. Device 3:100685. https:\/\/doi.org\/10.1016\/j.device.2024.100685","journal-title":"Device"},{"key":"12576_CR4","doi-asserted-by":"publisher","first-page":"v190","DOI":"10.1093\/annonc\/mdq187","volume":"21","author":"R Stupp","year":"2010","unstructured":"Stupp R, Tonn J-C, Brada M, Pentheroudakis G (2010) High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:v190\u2013v193. https:\/\/doi.org\/10.1093\/annonc\/mdq187","journal-title":"Ann Oncol"},{"key":"12576_CR5","doi-asserted-by":"publisher","first-page":"21268","DOI":"10.18632\/aging.203443","volume":"13","author":"D Yin","year":"2021","unstructured":"Yin D, Jin G, He H et al (2021) Celecoxib reverses the glioblastoma chemo-resistance to temozolomide through mitochondrial metabolism. Aging 13:21268\u201321282. https:\/\/doi.org\/10.18632\/aging.203443","journal-title":"Aging"},{"key":"12576_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41568-025-00824-9","volume":"25","author":"A Soragni","year":"2025","unstructured":"Soragni A, Knudsen ES, O\u2019Connor TN et al (2025) Acquired resistance in cancer: towards targeted therapeutic strategies. Nat Rev Cancer 25:613\u2013633. https:\/\/doi.org\/10.1038\/s41568-025-00824-9","journal-title":"Nat Rev Cancer"},{"key":"12576_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41392-026-02850-x","volume":"11","author":"K-Y Zhang","year":"2026","unstructured":"Zhang K-Y, Zhu X-Z, Yan Y-X et al (2026) Tumor evolution: signaling pathways, molecular mechanisms and therapeutic targets. Sig Transduct Target Ther 11:280. https:\/\/doi.org\/10.1038\/s41392-026-02850-x","journal-title":"Sig Transduct Target Ther"},{"key":"12576_CR8","doi-asserted-by":"publisher","first-page":"101836","DOI":"10.1016\/j.mito.2023.101836","volume":"75","author":"H-Y Li","year":"2024","unstructured":"Li H-Y, Feng Y-H, Lin C-L, Hsu T-I (2024) Mitochondrial Mechanisms in Temozolomide Resistance: Unraveling the Complex Interplay and Therapeutic Strategies in Glioblastoma. Mitochondrion 75:101836. https:\/\/doi.org\/10.1016\/j.mito.2023.101836","journal-title":"Mitochondrion"},{"key":"12576_CR9","doi-asserted-by":"publisher","unstructured":"Singh N, Miner A, Hennis L, Mittal S (2020) Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. https:\/\/doi.org\/10.20517\/cdr.2020.79. CDR","DOI":"10.20517\/cdr.2020.79"},{"key":"12576_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41467-024-54728-7","volume":"16","author":"S Punzi","year":"2025","unstructured":"Punzi S, Cittaro D, Gatti G et al (2025) Early tolerance and late persistence as alternative drug responses in cancer. Nat Commun 16:1291. https:\/\/doi.org\/10.1038\/s41467-024-54728-7","journal-title":"Nat Commun"},{"key":"12576_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41419-025-07617-w","volume":"16","author":"P Wang","year":"2025","unstructured":"Wang P, Liao B, Gong S et al (2025) Temozolomide promotes glioblastoma stemness expression through senescence-associated reprogramming via HIF1\u03b1\/HIF2\u03b1 regulation. Cell Death Dis 16:317. https:\/\/doi.org\/10.1038\/s41419-025-07617-w","journal-title":"Cell Death Dis"},{"key":"12576_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13046-023-02811-0","volume":"42","author":"A Visioli","year":"2023","unstructured":"Visioli A, Trivieri N, Mencarelli G et al (2023) Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies. J Exp Clin Cancer Res 42:244. https:\/\/doi.org\/10.1186\/s13046-023-02811-0","journal-title":"J Exp Clin Cancer Res"},{"key":"12576_CR13","doi-asserted-by":"publisher","first-page":"vdab163","DOI":"10.1093\/noajnl\/vdab163","volume":"4","author":"\u00c1FL Rios","year":"2022","unstructured":"Rios \u00c1FL, Tirapelli DPDC, Cirino MLDA et al (2022) Expression of pluripotency-related genes in human glioblastoma. Neuro-Oncology Adv 4:vdab163. https:\/\/doi.org\/10.1093\/noajnl\/vdab163","journal-title":"Neuro-Oncology Adv"},{"key":"12576_CR14","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1080\/15384101.2015.1090063","volume":"14","author":"B Banelli","year":"2015","unstructured":"Banelli B, Carra E, Barbieri F et al (2015) The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. Cell Cycle 14:3418\u20133429. https:\/\/doi.org\/10.1080\/15384101.2015.1090063","journal-title":"Cell Cycle"},{"key":"12576_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/cancers14020369","volume":"14","author":"S Sani","year":"2022","unstructured":"Sani S, Pallaoro N, Messe M et al (2022) Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of \u03b15\u03b21 Integrin. Cancers 14:369. https:\/\/doi.org\/10.3390\/cancers14020369","journal-title":"Cancers"},{"key":"12576_CR16","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1038\/s41598-025-86599-3","volume":"15","author":"B Priya","year":"2025","unstructured":"Priya B, Kirubakaran S (2025) TLK1 as a therapeutic target in TMZ resistant glioblastoma using small molecule inhibitor. Sci Rep 15:14691. https:\/\/doi.org\/10.1038\/s41598-025-86599-3","journal-title":"Sci Rep"},{"key":"12576_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41419-019-2200-2","volume":"11","author":"M Rab\u00e9","year":"2020","unstructured":"Rab\u00e9 M, Dumont S, \u00c1lvarez-Arenas A et al (2020) Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma. Cell Death Dis 11:19. https:\/\/doi.org\/10.1038\/s41419-019-2200-2","journal-title":"Cell Death Dis"},{"key":"12576_CR18","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.3892\/or.2016.4737","volume":"35","author":"S-G Jin","year":"2016","unstructured":"Jin S-G, Ryu H-H, Li S-Y et al (2016) Nogo-A inhibits the migration and invasion of human malignant glioma U87MG cells. Oncol Rep 35:3395\u20133402. https:\/\/doi.org\/10.3892\/or.2016.4737","journal-title":"Oncol Rep"},{"key":"12576_CR19","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1038\/s41467-022-29912-2","volume":"13","author":"X Lu","year":"2022","unstructured":"Lu X, Maturi NP, Jarvius M et al (2022) Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival. Nat Commun 13:2236. https:\/\/doi.org\/10.1038\/s41467-022-29912-2","journal-title":"Nat Commun"},{"key":"12576_CR20","doi-asserted-by":"publisher","first-page":"103925","DOI":"10.1016\/j.scr.2026.103925","volume":"91","author":"Y Chen","year":"2026","unstructured":"Chen Y, Zeng H, Ni K et al (2026) A method for detecting stemness of glioblastoma: 3D-tumor spheroid assay. Stem Cell Res 91:103925. https:\/\/doi.org\/10.1016\/j.scr.2026.103925","journal-title":"Stem Cell Res"},{"key":"12576_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/bios14110539","volume":"14","author":"H Jo","year":"2024","unstructured":"Jo H, Lee S, Kim M-H et al (2024) Recapitulating Glioma Stem Cell Niches Using 3D Spheroid Models for Glioblastoma Research. Biosensors 14:539. https:\/\/doi.org\/10.3390\/bios14110539","journal-title":"Biosensors"},{"key":"12576_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-0716-1225-5_3","volume-title":"In Vitro Models for Stem Cell Therapy","author":"JH McAbee","year":"2021","unstructured":"McAbee JH, Degorre-Kerbaul C, Tofilon PJ (2021) In Vitro Methods for the Study of Glioblastoma Stem-Like Cell Radiosensitivity. In: Stock P, Christ B (eds) In Vitro Models for Stem Cell Therapy. Springer US, New York, NY, pp 37\u201347"},{"key":"12576_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/life14060673","volume":"14","author":"D Smerdi","year":"2024","unstructured":"Smerdi D, Moutafi M, Kotsantis I et al (2024) Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data. Life 14:673. https:\/\/doi.org\/10.3390\/life14060673","journal-title":"Life"},{"key":"12576_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s40478-025-02046-4","volume":"13","author":"H Li","year":"2025","unstructured":"Li H, Wu Y, Chen Y et al (2025) Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights. acta neuropathol commun 13:126. https:\/\/doi.org\/10.1186\/s40478-025-02046-4","journal-title":"acta neuropathol commun"},{"key":"12576_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s41065-025-00564-8","volume":"162","author":"S Ghorbian","year":"2025","unstructured":"Ghorbian S (2025) Cancer cell plasticity and therapeutic resistance: mechanisms, crosstalk, and translational perspectives. Hereditas 162:188. https:\/\/doi.org\/10.1186\/s41065-025-00564-8","journal-title":"Hereditas"},{"key":"12576_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","volume":"43","author":"GR Bhat","year":"2024","unstructured":"Bhat GR, Sethi I, Sadida HQ et al (2024) Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. Cancer Metastasis Rev 43:197\u2013228. https:\/\/doi.org\/10.1007\/s10555-024-10172-z","journal-title":"Cancer Metastasis Rev"},{"key":"12576_CR27","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.29","author":"L Oliver","year":"2020","unstructured":"Oliver L, Lalier L, Salaud C et al (2020) Drug resistance in glioblastoma: are persisters the key to therapy? CDR. https:\/\/doi.org\/10.20517\/cdr.2020.29","journal-title":"CDR"},{"key":"12576_CR28","doi-asserted-by":"publisher","first-page":"620883","DOI":"10.3389\/fcell.2021.620883","volume":"9","author":"X-Y Gao","year":"2021","unstructured":"Gao X-Y, Zang J, Zheng M-H et al (2021) Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2\/NEAT1\/Wnt Pathway in Glioblastoma. Front Cell Dev Biol 9:620883. https:\/\/doi.org\/10.3389\/fcell.2021.620883","journal-title":"Front Cell Dev Biol"},{"key":"12576_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41420-022-01230-y","volume":"8","author":"L Gong","year":"2022","unstructured":"Gong L, Yin Y, Chen C et al (2022) Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma. Cell Death Discov 8:438. https:\/\/doi.org\/10.1038\/s41420-022-01230-y","journal-title":"Cell Death Discov"},{"key":"12576_CR30","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41588-025-02168-4","volume":"57","author":"A Spitzer","year":"2025","unstructured":"Spitzer A, Johnson KC, Nomura M et al (2025) Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics. Nat Genet 57:1168\u20131178. https:\/\/doi.org\/10.1038\/s41588-025-02168-4","journal-title":"Nat Genet"},{"key":"12576_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-021-00491-w","volume":"6","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhang H, Xu S et al (2021) The adaptive transition of glioblastoma stem cells and its implications on treatments. Sig Transduct Target Ther 6:124. https:\/\/doi.org\/10.1038\/s41392-021-00491-w","journal-title":"Sig Transduct Target Ther"},{"key":"12576_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41568-022-00486-x","volume":"22","author":"RC Gimple","year":"2022","unstructured":"Gimple RC, Yang K, Halbert ME et al (2022) Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity. Nat Rev Cancer 22:497\u2013514. https:\/\/doi.org\/10.1038\/s41568-022-00486-x","journal-title":"Nat Rev Cancer"},{"key":"12576_CR33","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/cancers15133458","volume":"15","author":"F Eckerdt","year":"2023","unstructured":"Eckerdt F, Platanias LC (2023) Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance. Cancers 15:3458. https:\/\/doi.org\/10.3390\/cancers15133458","journal-title":"Cancers"},{"key":"12576_CR34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/neuonc\/noab269","volume":"24","author":"YA Yabo","year":"2022","unstructured":"Yabo YA, Niclou SP, Golebiewska A (2022) Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma. Neurooncology 24:669\u2013682. https:\/\/doi.org\/10.1093\/neuonc\/noab269","journal-title":"Neurooncology"},{"key":"12576_CR35","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/s41388-019-1086-x","volume":"39","author":"B Manoranjan","year":"2020","unstructured":"Manoranjan B, Chokshi C, Venugopal C et al (2020) A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells. Oncogene 39:1590\u20131599. https:\/\/doi.org\/10.1038\/s41388-019-1086-x","journal-title":"Oncogene"},{"key":"12576_CR36","doi-asserted-by":"publisher","first-page":"36228","DOI":"10.1038\/s41598-025-20183-7","volume":"15","author":"N Savage","year":"2025","unstructured":"Savage N, Danis E, Chokshi CR et al (2025) CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastoma. Sci Rep 15:36228. https:\/\/doi.org\/10.1038\/s41598-025-20183-7","journal-title":"Sci Rep"},{"key":"12576_CR37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.stemcr.2014.01.005","volume":"2","author":"U Tiemann","year":"2014","unstructured":"Tiemann U, Marthaler AG, Adachi K et al (2014) Counteracting Activities of OCT4 and KLF4 during Reprogramming to Pluripotency. Stem Cell Rep 2:351\u2013365. https:\/\/doi.org\/10.1016\/j.stemcr.2014.01.005","journal-title":"Stem Cell Rep"},{"key":"12576_CR38","doi-asserted-by":"publisher","first-page":"13533","DOI":"10.1038\/srep13533","volume":"5","author":"N Tapia","year":"2015","unstructured":"Tapia N, MacCarthy C, Esch D et al (2015) Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency. Sci Rep 5:13533. https:\/\/doi.org\/10.1038\/srep13533","journal-title":"Sci Rep"},{"key":"12576_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-019-1228-7","volume":"10","author":"S Zhang","year":"2019","unstructured":"Zhang S, Bell E, Zhi H et al (2019) OCT4 and PAX6 determine the dual function of SOX2 in human ESCs as a key pluripotent or neural factor. Stem Cell Res Ther 10:122. https:\/\/doi.org\/10.1186\/s13287-019-1228-7","journal-title":"Stem Cell Res Ther"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12576-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12576-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:10:31Z","timestamp":1786432231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12576-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12576"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12576-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received ethical approval from The Ethic Committee of the Faculty of Medicine, Universitas Indonesia \u2013 Cipto Mangunkusumo Hospital, Jakarta, Indonesia (Approval number: KET-1407\/UN2.F1\/ETIK\/PPM.00.02\/2024).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1378"}}